stp938
Small moleculeexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Aug 3, 2022 (NCT05463263)
Timeline
2020s
- Jan 1, 2022
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- CTP synthase 1INHIBITOR
inhibitor - CTP synthase 1
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06786234 | Phase 1 | Mar 31, 2025 | Step Pharma, SAS |
| NCT06297525 | Phase 1 | Aug 2, 2024 | Step Pharma, SAS |
| NCT05463263 | Phase 1/Phase 2 (Phase 2) | Aug 3, 2022 | Step Pharma, SAS |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Step Pharma, SAS | For profit | 3 | 3 | 2 | 2022 |
1 organizations
Page 1 / 1